| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 78, 1145-1152, Copyright © 1994 by Endocrine Society
ARTICLES |
A Wedell, A Thilen, EM Ritzen, B Stengler and H Luthman
Rolf Luft Center for Diabetes Research, Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden.
We have characterized the disease-causing mutations in the steroid 21- hydroxylase genes of 127 patients with different clinical forms of congenital adrenal hyperplasia, representing 186 unrelated chromosomes. The gene was completely absent on 29.8% of the chromosomes, and this together with the I2 splice (27.7%), I173N (20.8%), V282L (5.4%), and R357W (3.8%) mutations constitute 87.5% of all affected chromosomes. In total, 15 different sequence aberrations combine to form 19 different disease-causing alleles. The results confirm that genotyping is an efficient means of diagnosing steroid 21-hydroxylase deficiency, although special consideration is needed to resolve genotypes when full families are not available. Clinical presentations of the different combinations of mutations indicate that genotyping is reliable for prediction of clinical outcome in patients with 21-hydroxylase deficiency. It is especially helpful in determining whether in utero treatment of affected females is indicated and in classifying the severity of 21-hydroxylase deficiency in children diagnosed through neonatal screening, before symptoms have appeared.
This article has been cited by other articles:
 |
|
 |
|
  K. Hagenfeldt, P.O. Janson, G. Holmdahl, H. Falhammar, H. Filipsson, L. Frisen, M. Thoren, and A. Nordenskjold Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Hum. Reprod., July 1, 2008; 23(7): 1607 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Menassa, V. Tardy, F. Despert, C. Bouvattier-Morel, J. P. Brossier, M. Cartigny, and Y. Morel p.H62L, a Rare Mutation of the CYP21 Gene Identified in Two Forms of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1901 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Merke Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 653 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nordenskjold, G. Holmdahl, L. Frisen, H. Falhammar, H. Filipsson, M. Thoren, P. O. Janson, and K. Hagenfeldt Type of Mutation and Surgical Procedure Affect Long-Term Quality of Life for Women with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 380 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Araujo, B. B. Mendonca, A. S. Barbosa, C. J. Lin, J. A. M. Marcondes, A. E. C. Billerbeck, and T. A. S. S. Bachega Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4028 - 4034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Baumgartner-Parzer, G. Fischer, and H. Vierhapper Predisposition for de Novo Gene Aberrations in the Offspring of Mothers with a Duplicated CYP21A2 Gene J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1164 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Falhammar, H. Filipsson, G. Holmdahl, P.-O. Janson, A. Nordenskjold, K. Hagenfeldt, and M. Thoren Metabolic Profile and Body Composition in Adult Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 110 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Grischuk, P. Rubtsov, F. G. Riepe, J. Grotzinger, S. Beljelarskaia, V. Prassolov, N. Kalintchenko, T. Semitcheva, V. Peterkova, A. Tiulpakov, et al. Four Novel Missense Mutations in the CYP21A2 Gene Detected in Russian Patients Suffering from the Classical Form of Congenital Adrenal Hyperplasia: Identification, Functional Characterization, and Structural Analysis J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4976 - 4980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Porzio, V. Cunsolo, M. Malaponti, E. De Nisco, A. Acquafredda, L. Cavallo, M. Andreani, E. Giardina, M. Testi, M. Cappa, et al. Divergent Phenotype of Two Siblings Human Leukocyte Antigen Identical, Affected by Nonclassical and Classical Congenital Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4510 - 4513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Luczay, D Torok, A Ferenczi, J Majnik, J Solyom, and G. Fekete Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency. Eur. J. Endocrinol., June 1, 2006; 154(6): 859 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Johannsen, C. P. L. Ripa, J. M. Reinisch, M. Schwartz, E. L. Mortensen, and K. M. Main Impaired Cognitive Function in Women with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1376 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Claahsen-van der Grinten, K. Noordam, G. F. Borm, and B. J. Otten Absence of Increased Height Velocity in the First Year of Life in Untreated Children with Simple Virilizing Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1205 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Dolz;an, J Solyom, G Fekete, J Kovacs, V Rakosnikova, F Votava, J Lebl, Z Pribilincova, S. Baumgartner-Parzer, S Riedl, et al. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia Eur. J. Endocrinol., July 1, 2005; 153(1): 99 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Robins, M. Barbaro, S. Lajic, and A. Wedell Not All Amino Acid Substitutions of the Common Cluster E6 Mutation in CYP21 Cause Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2148 - 2153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Baumgartner-Parzer, P. Nowotny, G. Heinze, W. Waldhausl, and H. Vierhapper Carrier Frequency of Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in a Middle European Population J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 775 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kosel, S. Burggraf, R. Fingerhut, H. G. Dorr, A. A. Roscher, and B. Olgemoller Rapid Second-Tier Molecular Genetic Analysis for Congenital Adrenal Hyperplasia Attributable to Steroid 21-Hydroxylase Deficiency Clin. Chem., February 1, 2005; 51(2): 298 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Krone, F. G. Riepe, J. Grotzinger, C.-J. Partsch, and W. G. Sippell Functional Characterization of Two Novel Point Mutations in the CYP21 Gene Causing Simple Virilizing Forms of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 445 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kharrat, V. Tardy, R. M'Rad, F. Maazoul, L. B. Jemaa, M. Refai, Y. Morel, and H. Chaabouni Molecular Genetic Analysis of Tunisian Patients with a Classic Form of 21-Hydroxylase Deficiency: Identification of Four Novel Mutations and High Prevalence of Q318X Mutation J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 368 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Hall, J. A. Jones, H. F. L. Meyer-Bahlburg, C. Dolezal, M. Coleman, P. Foster, D. A. Price, and P. E. Clayton Behavioral and Physical Masculinization Are Related to Genotype in Girls with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 419 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Balsamo, A. Cicognani, L. Baldazzi, M. Barbaro, F. Baronio, M. Gennari, M. Bal, A. Cassio, K. Kontaxaki, and E. Cacciari CYP21 Genotype, Adult Height, and Pubertal Development in 55 Patients Treated for 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5680 - 5688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Speiser and P. C. White Congenital Adrenal Hyperplasia N. Engl. J. Med., August 21, 2003; 349(8): 776 - 788. [Full Text] [PDF]
|
|
|
|
|
|
N. M. M. L. Stikkelbroeck, L. H. Hoefsloot, I. J. de Wijs, B. J. Otten, A. R. M. M. Hermus, and E. A. Sistermans CYP21 Gene Mutation Analysis in 198 Patients with 21-Hydroxylase Deficiency in The Netherlands: Six Novel Mutations and a Specific Cluster of Four Mutations J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3852 - 3859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pinto, V. Tardy, C. Trivin, C. Thalassinos, S. Lortat-Jacob, C. Nihoul-Fekete, Y. Morel, and R. Brauner Follow-Up of 68 Children with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Relevance of Genotype for Management J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2624 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Baumgartner-Parzer, P. Nowotny, W. Waldhausl, and H. Vierhapper A Rare Duplicated 21-Hydroxylase Haplotype and a de Novo Mutation: A Family Analysis J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2794 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P F J Koppens, H J M Smeets, I J de Wijs, and H J Degenhart Mapping of a de novo unequal crossover causing a deletion of the steroid 21-hydroxylase (CYP21A2) gene and a non-functional hybrid tenascin-X (TNXB) gene J. Med. Genet., May 1, 2003; 40(5): e53 - 53. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Berenbaum and J. M. Bailey Effects on Gender Identity of Prenatal Androgens and Genital Appearance: Evidence from Girls with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1102 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nordenstrom, A. Servin, G. Bohlin, A. Larsson, and A. Wedell Sex-Typed Toy Play Behavior Correlates with the Degree of Prenatal Androgen Exposure Assessed by CYP21 Genotype in Girls with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5119 - 5124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. C. Billerbeck, B. B. Mendonca, E. M. Pinto, G. Madureira, I. J. P. Arnhold, and T. A. S. S. Bachega Three Novel Mutations in CYP21 Gene in Brazilian Patients with the Classical Form of 21-Hydroxylase Deficiency Due to a Founder Effect J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4314 - 4317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Speiser Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3029 - 3030. [Full Text] [PDF]
|
|
|
|
|
|
E. Charmandari, G. Eisenhofer, S. L. Mehlinger, A. Carlson, R. Wesley, M. F. Keil, G. P. Chrousos, M. I. New, and D. P. Merke Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3031 - 3037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tiitinen and M. Valimaki Primary Infertility in 45-Year-Old Man with Untreated 21-Hydroxylase Deficiency: Successful Outcome with Glucocorticoid Therapy J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2442 - 2445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. L. Giwercman, A. Nordenskjold, E. M. Ritzen, K. O. Nilsson, S.-A. Ivarsson, U. Grandell, and A. Wedell An Androgen Receptor Gene Mutation (E653K) in a Family with Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency as well as in Partial Androgen Insensitivity J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2623 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Koyama, T. Toyoura, S. Saisho, K. Shimozawa, and J. Yata Genetic Analysis of Japanese Patients with 21-Hydroxylase Deficiency: Identification of a Patient with a New Mutation of a Homozygous Deletion of Adenine at Codon 246 and Patients without Demonstrable Mutations within the Structural Gene for CYP21 J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2668 - 2673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lajic, S. Clauin, T. Robins, P. Vexiau, H. Blanche, C. Bellanne-Chantelot, and A. Wedell Novel Mutations in CYP21 Detected in Individuals with Hyperandrogenism J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2824 - 2829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Krone, A. Braun, S. Weinert, M. Peter, A. A. Roscher, C.-J. Partsch, and W. G. Sippell Multiplex Minisequencing of the 21-Hydroxylase Gene as a Rapid Strategy to Confirm Congenital Adrenal Hyperplasia Clin. Chem., June 1, 2002; 48(6): 818 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Merke, S. R. Bornstein, N. A. Avila, and G. P. Chrousos Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Ann Intern Med, February 19, 2002; 136(4): 320 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Olney, E. B. Mougey, J. Wang, D. I. Shulman, and J. E. Sylvester Using Real-Time, Quantitative PCR for Rapid Genotyping of the Steroid 21-Hydroxylase Gene in a North Florida Population J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 735 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. S. S. Bachega, E. M. L. Brenlha, A. E. C. Billerbeck, J. A. M. Marcondes, G. Madureira, I. J. P. Arnhold, and B. B. Mendonca Variable ACTH-Stimulated 17-Hydroxyprogesterone Values in 21-Hydroxylase Deficiency Carriers Are Not Related to the Different CYP21 Gene Mutations J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 786 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Baumgartner-Parzer, E. Schulze, W. Waldhausl, S. Pauschenwein, S. Rondot, P. Nowotny, K. Meyer, H. Frisch, F. Waldhauser, and H. Vierhapper Mutational Spectrum of the Steroid 21-Hydroxylase Gene in Austria: Identification of a Novel Missense Mutation J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4771 - 4775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nordenstrom, A. Wedell, L. Hagenfeldt, C. Marcus, and A. Larsson Neonatal Screening for Congenital Adrenal Hyperplasia: 17-Hydroxyprogesterone Levels and CYP21 Genotypes in Preterm Infants Pediatrics, October 1, 2001; 108(4): e68 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dracopoulou-Vabouli, M. Maniati-Christidi, and C. Dacou-Voutetakis The Spectrum of Molecular Defects of the CYP21 Gene in the Hellenic Population: Variable Concordance between Genotype and Phenotype in the Different Forms of Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2845 - 2848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Deneux, V. Tardy, A. Dib, E. Mornet, L. Billaud, D. Charron, Y. Morel, and F. Kuttenn Phenotype-Genotype Correlation in 56 Women with Nonclassical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 207 - 213. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. C. White and P. W. Speiser Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Endocr. Rev., June 1, 2000; 21(3): 245 - 291. [Abstract] [Full Text]
|
|
|
|
 |
|
 C G D Brook;, I. HUGHES;, and C. J H KELNAR Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2000; 82(3): 176F - 181. [Full Text]
|
|
|
|
|
|
N. Krone, A. Braun, A. A. Roscher, D. Knorr, and H. P. Schwarz Predicting Phenotype in Steroid 21-Hydroxylase Deficiency? Comprehensive Genotyping in 155 Unrelated, Well Defined Patients from Southern Germany J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1059 - 1065. [Abstract] [Full Text]
|
|
|
|
|
|
S. A. Berenbaum, S. C. Duck, and K. Bryk Behavioral Effects of Prenatal Versus Postnatal Androgen Excess in Children with 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 727 - 733. [Abstract] [Full Text]
|
|
|
|
|
|
A. E. C. Billerbeck, T. A. S. S. Bachega, E. T. Frazzatto, M. Y. Nishi, A. C. Goldberg, M. L. C. Marin, G. Madureira, O. Monte, I. J. P. Arnhold, and B. B. Mendonca A Novel Missense Mutation, GLY424SER, in Brazilian Patients with 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2870 - 2872. [Abstract] [Full Text]
|
|
|
|
|
|
A. Ferenczi, M. Garami, E. Kiss, M. Pék, M. Sasvári-Székely, C. Barta, M. Staub, J. Sólyom, and G. Fekete Screening for Mutations of 21-Hydroxylase Gene in Hungarian Patients with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2369 - 2372. [Abstract] [Full Text]
|
|
|
|
|
|
A. Nordenström, A. Thilén, L. Hagenfeldt, A. Larsson, and A. Wedell Genotyping Is a Valuable Diagnostic Complement to Neonatal Screening for Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1505 - 1509. [Abstract] [Full Text]
|
|
|
|
|
|
A. Nordenström, C. Marcus, M. Axelson, A. Wedell, and E. M. Ritzén Failure of Cortisone Acetate Treatment in Congenital Adrenal Hyperplasia because of Defective 11{beta}-Hydroxysteroid Dehydrogenase Reductase Activity J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1210 - 1213. [Abstract] [Full Text]
|
|
|
|
|
|
J. Fitness, N. Dixit, D. Webster, T. Torresani, R. Pergolizzi, P. W. Speiser, and D. J. Day Genotyping of CYP21, Linked Chromosome 6p Markers, and a Sex-Specific Gene in Neonatal Screening for Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 960 - 966. [Abstract] [Full Text]
|
|
|
|
|
|
M. Lako, S. Ramsden, R D. Campbell, and T. Strachan Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis J. Med. Genet., February 1, 1999; 36(2): 119 - 124. [Abstract] [Full Text]
|
|
|
|
|
|
T. A. S. S. Bachega, A. E. C. Billerbeck, G. Madureira, J. A. M. Marcondes, C. A. Longui, M. V. Leite, I. J. P. Arnhold, and B. B. Mendonca Molecular Genotyping in Brazilian Patients with the Classical and Nonclassical Forms of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4416 - 4419. [Abstract] [Full Text]
|
|
|
|
|
|
N. Krone, A. A. Roscher, H. P. Schwarz, and A. Braun Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency Clin. Chem., October 1, 1998; 44(10): 2075 - 2082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Fardella, H. Poggi, P. Pineda, J. Soto, I. Torrealba, A. Cattani, E. Oestreicher, and A. Foradori Salt-Wasting Congenital Adrenal Hyperplasia: Detection of Mutations in CYP21B Gene in a Chilean Population J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3357 - 3360. [Abstract] [Full Text]
|
|
|
|
|
|
D. Chin, P. W. Speiser, J. Imperato-McGinley, N. Dixit, N. Uli, R. David, and S. E. Oberfield Study of a Kindred with Classic Congenital Adrenal Hyperplasia: Diagnostic Challenge due to Phenotypic Variance J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1940 - 1945. [Abstract] [Full Text]
|
|
|
|
|
|
A. Thilen, A. Nordenstrom, L. Hagenfeldt, U. von Dobeln, C. Guthenberg, and A. Larsson Benefits of Neonatal Screening for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in Sweden Pediatrics, April 1, 1998; 101 (4): e11 - e11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nikoshkov, S. Lajic, A. Vlamis-Gardikas, L. Tranebjarg, M. Holst, A. Wedell, and H. Luthman Naturally Occurring Mutants of Human Steroid 21-Hydroxylase (P450c21) Pinpoint Residues Important for Enzyme Activity and Stability J. Biol. Chem., March 13, 1998; 273(11): 6163 - 6165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jaaskelainen, A. Levo, R. Voutilainen, and J. Partanen Population-Wide Evaluation of Disease Manifestation in Relation to Molecular Genotype in Steroid 21-Hydroxylase (CYP21) Deficiency: Good Correlation in a Well Defined Population J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3293 - 3297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tajima, K. F. Jun Nakae, T. Toyoura, K. Shimozawa, S. Kusuda, K. Goji, T. Nagashima, and G. B. Cutler Jr. Molecular Basis of Nonclassical Steroid 21-Hydroxylase Deficiency Detected by Neonatal Mass Screening in Japan J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2350 - 2356. [Abstract] [Full Text] |
